Literature DB >> 26415991

The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institution.

Yoshikane Yamauchi1, Thomas Muley2, Seyer Safi1, Stefan Rieken3, Helge Bischoff4, Jutta Kappes5, Arne Warth6, Felix J F Herth7, Hendrik Dienemann1, Hans Hoffmann8.   

Abstract

PURPOSE: To investigate the hazard function of tumor recurrence in patients with completely (R0) resected non-small cell lung cancer.
METHODS: A total of 1374 patients treated between 2003 and 2009 with complete resection and systematic lymph node dissection were studied. The risk of recurrence at a given time after operation was studied utilizing the cause-specific hazard function. Recurrence was categorized as local recurrence or distant recurrence. The risk distribution was assessed using clinical and pathological factors.
RESULTS: The hazard function for recurrence presented an early peak at approximately 10 months after surgery and maintained a tapered plateau-like tail extending up to 8 years. A similar risk pattern was detected for both local recurrence and distant recurrence, while the risk of distant recurrence was higher than that of local recurrence. The double-peaked pattern of hazard rate was present in several subgroups, such as p-stage IA patients. A comparison of histology and status of nodal involvement showed that pN1-2 adenocarcinoma patients demonstrated a high hazard rate of distant recurrence and that pN0 adenocarcinoma patients exhibited a small recurrent risk for a longer time. Squamous cell carcinoma patients showed only little difference in risk.
CONCLUSIONS: The data may be useful to select patients at high risk of recurrence and may provide information for each patient to decide how to manage the postoperative follow-up individually.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hazard function; Non-small cell lung cancer; Recurrence

Mesh:

Year:  2015        PMID: 26415991     DOI: 10.1016/j.lungcan.2015.09.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.

Authors:  Seyer Safi; Yoshikane Yamauchi; Anchana Rathinasamy; Slava Stamova; Martin Eichhorn; Arne Warth; Geraldine Rauch; Hendrik Dienemann; Hans Hoffmann; Philipp Beckhove
Journal:  Oncoimmunology       Date:  2017-09-08       Impact factor: 8.110

2.  Characteristics and timing of recurrence during postoperative surveillance after curative resection for lung adenocarcinoma.

Authors:  Terumoto Koike; Tatsuya Goto; Akihiko Kitahara; Seijiro Sato; Masayuki Saitoh; Takehisa Hashimoto; Osamu Namura; Masashi Takahashi; Shin-Ichi Toyabe; Masanori Tsuchida
Journal:  Surg Today       Date:  2017-05-04       Impact factor: 2.549

3.  Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis.

Authors:  Hitoshi Dejima; Hiroaki Kuroda; Yuko Oya; Noriaki Sakakura; Yoshitaka Inaba; Tsuneo Tamaki; Yasushi Yatabe; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

4.  A surveillance method-oriented detection of post-operative spatial-temporal recurrence for non-small cell lung cancer.

Authors:  Jun-Jie Xi; Jia-Cheng Yin; Lin Wang; Chun-Lai Lu; Qun Wang; Wei Jiang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

5.  Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model.

Authors:  Zhirui Fan; Wenhua Xue; Lifeng Li; Chaoqi Zhang; Jingli Lu; Yunkai Zhai; Zhenhe Suo; Jie Zhao
Journal:  J Transl Med       Date:  2018-07-20       Impact factor: 5.531

6.  Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance.

Authors:  Yusuke Takahashi; Takashi Eguchi; Koji Kameda; Shaohua Lu; Raj G Vaghjiani; Kay See Tan; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Oncotarget       Date:  2018-11-06

7.  Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer.

Authors:  Seyer Safi; Yoshikane Yamauchi; Slava Stamova; Anchana Rathinasamy; Jan Op den Winkel; Simone Jünger; Mariana Bucur; Ludmilla Umansky; Arne Warth; Esther Herpel; Martin Eichhorn; Hauke Winter; Hans Hoffmann; Philipp Beckhove
Journal:  Oncoimmunology       Date:  2019-10-23       Impact factor: 8.110

8.  Prediction of Overall Survival of Patients with Completely Resected Non-Small Cell Lung Cancer: Analyses of Preoperative Spirometry, Preoperative Blood Tests, and Other Clinicopathological Data.

Authors:  Mengkun Shi; Cheng Zhan; Jialun Shi; Qun Wang
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

9.  Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer.

Authors:  Seyer Safi; Yoshikane Yamauchi; Hans Hoffmann; Wilko Weichert; Philipp J Jost; Hauke Winter; Thomas Muley; Philipp Beckhove
Journal:  Cancers (Basel)       Date:  2020-11-24       Impact factor: 6.639

10.  Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomas.

Authors:  Helen Pasternack; Christiane Kuempers; Mario Deng; Iris Watermann; Till Olchers; Mark Kuehnel; Danny Jonigk; Christian Kugler; Florian Stellmacher; Torsten Goldmann; Jutta Kirfel; Ole Ammerpohl; Sven Perner; Martin Reck
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.